Vista Pharma advances on signing NDA to acquire complex ANDA for UROCARE

29 May 2018 Evaluate

Vista Pharmaceuticals is currently trading at Rs. 36.90, up by 3.35 points or 9.99% from its previous closing of Rs. 33.55 on the BSE.

The scrip opened at Rs. 33.40 and has touched a high and low of Rs. 36.90 and Rs. 33.00 respectively. So far 25040 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 2 has touched a 52 week high of Rs. 56.15 on 01-Mar-2018 and a 52 week low of Rs. 25.70 on 16-Aug-2017.

Last one week high and low of the scrip stood at Rs. 37.20 and Rs. 33.00 respectively. The current market cap of the company is Rs. 107.55 crore.

The promoters holding in the company stood at 35.56%, while Institutions and Non-Institutions held 0.36% and 64.08% respectively.

Vista Pharmaceuticals has signed a Non-Disclosure Agreement (NDA) with a company to acquire a complex ANDA for UROCARE. The US market size for this BRAND is $1.3 billion (Rs 8,840 crore) as per the latest IMS data. This ANDA will be manufactured at another USFDA approved Contract Manufacturing Facility (CMO) for 2 years.

The company already filed a complex ANDA in September 2017, targeting Cardialgy segment with a market size of $200 million (Rs 1,360 crore) as per latest IMS data. This product has a limited competition in the market and hence the company is expecting good revenues and profits from this product.

Vista Pharmaceuticals is engaged in manufacturing and selling of pharmaceutical, medical and veterinary preparations. The company also sells the products to its related companies, which are engaged in the manufacture of formulations.


Vista Pharma Share Price

8.58 0.31 (3.75%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×